Isomorphic Labs raises $5B Series C co-led by Greenoaks and Sequoia

SergeiIakhnin · x · 2026-11-17

Isomorphic Labs, the AI drug design company spun out of DeepMind, announced a $5 billion Series C co-led by Greenoaks and Sequoia Capital, with a16z joining as a new investor and Alphabet continuing to invest significantly. All existing investors — Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund — participated.

The funds will scale its proprietary drug design engine (IsoDDE) and its pipeline of AI-designed therapeutic candidates.

Related event: Isomorphic Labs Raises $5 Billion to Solve All Disease with AI(6 posts)→

Original post →

More from Venture

Venture channel →